Protein profiling of organic stone matrix and urine from dogs with urolithiasis

Journal of Animal Physiology and Animal Nutrition

Volumn 90, Issue 5-6, 2006, Pages 192-199

  Forterre, S ^a   Raila, J ^a   Kohn, B ^b   Brunnberg, L ^b   Schweigert, F J ^a  

^a UNIVERSITY OF POTSDAM   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; MAGNESIUM DERIVATIVE; PHOSPHATE; STRUVITE; URIC ACID;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMISTRY; DOG; DOG DISEASE; FEMALE; MALE; MASS SPECTROMETRY; METABOLISM; MOLECULAR WEIGHT; PROTEIN INTAKE; URINALYSIS; URINE; UROLITHIASIS;

ANIMALS; CALCIUM OXALATE; DIETARY PROTEINS; DOG DISEASES; DOGS; FEMALE; MAGNESIUM COMPOUNDS; MALE; MOLECULAR WEIGHT; PHOSPHATES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; URIC ACID; URINALYSIS; URINARY CALCULI;

CANIS FAMILIARIS;

EID: 33646709187     PISSN: 09312439     EISSN: 14390396     Source Type: Journal    
DOI: 10.1111/j.1439-0396.2005.00590.x     Document Type: Article

References (33)

1. Ardekani, A. M. Liotta, L. A. Petricoin, E. F., 2002: Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert Review of Molecular Diagnostics 2, 312 320.
2. Austen, B. M. Frears, E. R. Davies, H., 2000: The use of ProteinChip arrays to monitor production of Alzheimer's beta amyloid in transfected cells. Journal of Peptide Science 6, 459 469.
3. Binette, J. P. Binette, M. B., 1994: Sequencing of proteins extracted from stones. Scanning Microscopy 8, 233 239.
4. Boyce, W. H., 1968: Organic matrix of human urinary concretions. American Journal of Medicine 45, 673 683.
5. Boyce, W. H. Garvey, F. K., 1956: The amount and nature of the organic matrix in urinary calculi: a review. Journal of Urology 76, 213 227.
6. Boyce, W. H. King, J. S. Fielden, M. L., 1962: Total non-dialyzable solids in human urine XIII. Immunological detection of a component peculiar to renal calculous matrix and to urine of calculous patients. Journal of Clinical Investigation 41, 1180 1189.
7. Carvalho, M. Lulich, J. P. Osborne, C. A. Nakagawa, Y., 2003: Role of urinary inhibitors of crystallization in uric acid nephrolithiasis: Dalmatian dog model. Urology 62, 566 570.
8. Cutillas, P. R. Norden, A. G. Cramer, R. Burlingame, A. L. Unwin, R. J., 2003: Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome. Clinical Science (London) 104, 483 490.
9. Doyle, I. R. Ryall, R. L. Marshall, V. R., 1991: Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. Clinical Chemistry 37, 1589 1594.
10. Dussol, B Berland, Y., 1996: Urinary kidney stone inhibitors. Where are we?. Nephrology Dialysis and Transplantation 11, 1222 1224.
11. Dussol, B. Geider, S. Lilova, A. Leonetti, F. Dupuy, P. Daudon, M. Berland, Y. Dagorn, J. C. Verdier, J. M., 1995: Analysis of the soluble organic matrix of five morphologically different kidney stones. Evidence for a specific role of albumin in the constitution of the stone protein matrix. Urological Research 23, 45 51.
12. Fleisch, H., 1978: Inhibitors and promoters of stone formation. Kidney International 13, 361 371.
13. Gygi, S. P. Corthals, G. L. Zhang, Y. Rochon, Y. Aebersold, R., 2000: Evaluation of two-dimensional gel electrophoresis - based proteome analysis technology. Proceedings of the National Academy of Sciences 97, 9390 9395.
14. Hampel, D. J. Sansome, C. Sha, M. Brodsky, S. Lawson, W. E. Goligorsky, M. S., 2001: Toward proteomics in uroscopy: urinary protein profiles after radiocontrast medium administration. Journal of the American Society of Nephrology 12, 1026 1035.
15. Hess, B. Nakagawa, Y. Parks, J. H. Coe, F. L., 1991: Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. American Journal of Physiology 260, F569 F578.
16. Khan, S. R. Kok, D. J., 2004: Modulators of urinary stone formation. Frontiers in Bioscience 9, 1450 1482.
17. Koide, T. Takemoto, M. Itatani, H. Takaha, M. Sonoda, T., 1981: Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation. Investigative Urology 18, 382 386.
18. Martin, X. Opgennorth, T. J. Werness, P. G. Rundquist, R. T. Romero, J. C. Smith, L. H., 1985: Bladder secretion of inhibitors of calcium oxalate crystal growth. Kidney International 28, 636 639.
19. Morse, R. M. Resnick, M. I., 1989: A study of the incorporation of urinary macromolecules onto crystals of different mineral compositions. Journal of Urology 141, 641 644.
20. Nakagawa, Y. Ahmed, M. Hall, S. L. Deganello, S. Coe, F. L., 1987: Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. Journal of Clinical Investigation 79, 1782 1787.
21. Osborne, C. A. Clinton, C. W. Bamman, L. K. Moran, H. C. Coston, B. R. Frost, A. P., 1986a: Prevalence of canine uroliths. Minnesota Urolith Center. Veterinary Clinics of North America. Small Animal Practice 16, 27 44.
22. Osborne, C. A. Klausner, J. S. Polzin, D. J. Griffith, D. P., 1986b: Etiopathogenesis of canine struvite urolithiasis. Veterinary Clinics of North America. Small Animal Practice 16, 67 86.
23. Osborne, C. A. Poffenbarger, E. M. Klausner, J. S. Johnston, S. D. Griffith, D. P., 1986c: Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis. Veterinary Clinics of North America. Small Animal Practice 16, 133 170.
24. Osborne, C. A. Sanderson, S. L. Lulich, J. P. Bartges, J. W. Ulrich, L. K. Koehler, L. A. Bird, K. A. Swanson, L. L., 1999: Canine cystine urolithiasis. Cause, detection, treatment, and prevention. Veterinary Clinics of North America. Small Animal Practice 29, 193 211.
25. Raila, J. Forterre, S. Schweigert, F. J., 2003: Levels of retinol and retinyl esters in plasma and urine of dogs with urolithiasis. Journal of Veterinary Medicine A, Physiology Pathology Clinical Medicine 50, 380 382.
26. Robertson, W. G. Jones, J. S. Heaton, M. A. Stevenson, A. E. Markwell, P. J., 2002: Predicting the crystallization potential of urine from cats and dogs with respect to calcium oxalate and magnesium ammonium phosphate (struvite). Journal of Nutrition 32, 1637S 1641S.
27. Rodgers, A. L. Irving, R. A. Mezzabotta, M. Benloulou, P., 1986: Struvite crystalluria and urolithiasis in cross Labradors. Scanning Electron Microscopy Pt3, 1169 1174.
28. Rose, G. A. Sulaiman, S., 1984: Effect of different fractions of macromolecules upon triggering of calcium oxalate and calcium phosphate crystal formation in whole urine. Urologia Internationalis 39, 147 149.
29. Schaub, S. Wilkins, J. Weiler, T. Sangster, K. Rush, D. Nickerson, P., 2004: Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney International 65, 323 332.
30. Siddiqui, A. A. Sultana, T. Buchholz, N. P. Waqar, M. A. Talati, J., 1998: Proteins in renal stones and urine of stone formers. Urological Research 26, 383 388.
31. Vlahou, A. Schellhammer, P. F. Medrinos, S. Kondylis, F. I. Gong, L. Nasim, S. Wright, G. L., 2001: Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. American Journal of Pathology 158, 1491 1501.
32. Wright, G. L. Cazares, L. H. Leung, S. M. Leung, S. M. Nasim, S. Adam, B. Yip, T. Schellhammer, P. F. Gong, L. Vlahou, A., 2000: Proteinchip-surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip thechnology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer and Prostatic Diseases 2, 264 276.
33. Zhou, H. Ranish, J. A. Watts, J. D. Aebersold, R., 2002: Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry. Nature Biotechnology 20, 512 515.